Literature DB >> 11219225

Cerebral salt wasting syndrome.

M R Harrigan1.   

Abstract

There is significant evidence to show that many patients with hyponatremia and intracranial disease who were previously diagnosed with SIADH actually have CSW. The critical difference between SIADH and CSW is that CSW involves renal salt loss leading to hyponatremia and volume loss, whereas SIADH is a euvolemic or hypervolemic condition. Attention to volume status in patients with hyponatremia is essential. The primary treatment for CSW is water and salt replacement. The mechanisms underlying CSW are not understood but may involve ANP or other natriuretic factors and direct neural influence on renal function. Future investigation is needed to better define the incidence of CSW in patients with intracranial disease, identify other disorders that can lead to CSW, and elucidate the mechanisms underlying this syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219225     DOI: 10.1016/s0749-0704(05)70155-x

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  24 in total

1.  Inferior vena cava distensibility as a predictor of fluid responsiveness in patients with subarachnoid hemorrhage.

Authors:  Riccardo Moretti; Barbara Pizzi
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

2.  Clinical evaluation of hyponatremia and hypovolemia in critically ill adult neurologic patients: contribution of the use of cumulative balance of sodium.

Authors:  Paolo Gritti; Luigi Andrea Lanterna; Lidia Rotasperti; Matteo Filippini; Simone Cazzaniga; Carlo Brembilla; Tatyana Sarnecki; Ferdinando Luca Lorini
Journal:  J Anesth       Date:  2014-03-21       Impact factor: 2.078

3.  Cerebral salt wasting syndrome in patients with minor head trauma - two case reports.

Authors:  Gabriela Csipak; Natalia Hagau
Journal:  Rom J Anaesth Intensive Care       Date:  2016-10

4.  Cerebral correlates of hyponatremia.

Authors:  Barnett R Nathan
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

5.  Evaluation of Phytocannabinoids from High Potency Cannabis sativa using In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2.

Authors:  Afeef S Husni; Christopher R McCurdy; Mohamed M Radwan; Safwat A Ahmed; Desmond Slade; Samir A Ross; Mahmoud A ElSohly; Stephen J Cutler
Journal:  Med Chem Res       Date:  2014-09-01       Impact factor: 1.965

6.  Cerebral salt wasting syndrome in a patient affected of spontaneous frontoparietal subdural haematoma.

Authors:  Mariaina Cerdá-Esteve; Mariona Badia; Javier Trujillano; Cecília Vilanova; Javier Maravall; Dídac Mauricio
Journal:  BMJ Case Rep       Date:  2009-10-13

7.  Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.

Authors:  Carolyn H Woo; Vivek A Rao; William Sheridan; Alexander C Flint
Journal:  Neurocrit Care       Date:  2009-06-16       Impact factor: 3.210

8.  Hyponatraemia and hypovolemic shock with tuberculous meningitis.

Authors:  Rashna Dass; Ravishankar Nagaraj; Jayashree Murlidharan; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

9.  Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Lily Kao; Zahraa Al-Lawati; Joli Vavao; Gary K Steinberg; Laurence Katznelson
Journal:  Pituitary       Date:  2009-05-22       Impact factor: 4.107

Review 10.  Tumor-related hyponatremia.

Authors:  Adedayo A Onitilo; Ebenezer Kio; Suhail A R Doi
Journal:  Clin Med Res       Date:  2007-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.